SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
01-Apr-21 7:58 PM View: | Pandion Therapeutics, Inc. (PAND) | 01-Apr-21 | Disposition (change in control) | 87,764 | $60.00 | $5,265,840.00 | (100%) 87.76K to 0 | (< 1%) |
08-Mar-21 7:10 PM View: | Morphic Holding, Inc. (MORF) | 05-Mar-21 | Market Purchase | 1,000 | $70.00 | $70,000.00 | 100% 0 to 1.0K | < 1% |
21-Jul-20 7:39 PM View: | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Conversion | 7,044 | -- | -- | 9% 79.27K to 86.31K | |
21-Jul-20 7:39 PM View: | Pandion Therapeutics, Inc. (PAND) | 21-Jul-20 | Purchase | 1,450 | $18.00 | $26,100.00 | 2% 86.31K to 87.76K | |
01-Jul-19 7:23 PM View: | Morphic Holding, Inc. (MORF) | 01-Jul-19 | Conversion | 2,300,440 | -- | -- | 100% 0 to 2.3M | |
01-Jul-19 7:23 PM View: | Morphic Holding, Inc. (MORF) | 01-Jul-19 | Purchase | 333,333 | $15.00 | $5,000,000.00 | 14% 2.3M to 2.63M | |
07-Nov-17 4:06 PM View: | Spero Therapeutics, Inc. (SPRO) | 06-Nov-17 | Conversion | 1,425,440 | -- | -- | 100% 0 to 1.43M | |
07-Nov-17 4:06 PM View: | Spero Therapeutics, Inc. (SPRO) | 06-Nov-17 | Purchase | 428,571 | $14.00 | $5,999,990.00 | 30% 1.43M to 1.85M |